Przejdź do zawartości
· Wypełniacze skórne
SKU 11158 · GTIN 0107640173232117

Teosyal Puresense Redensity 2

Dostępny
Objętość
2 x 1 mL
Laboratorium
Teoxane
Pochodzenie
Szwajcaria
Wskazanie
Periorbital and midface fine line, wrinkle and depression correction
Cena hurtowa i historia tylko dla zweryfikowanych
allpara zaopatruje licencjonowanych specjalistów. Zaloguj się lub załóż konto B2B, aby zobaczyć aktualne ceny, progi ilościowe i historię cen.

TEOSYAL PureSense Redensity 2 is a transparent, sterile, non-pyrogenic and viscoelastic hyaluronic acid filler of non-animal origin from Teoxane SA in Geneva, created as the periorbital reference of the range. It is indicated to correct superficial fine lines, wrinkles and depressions located around the eyes. Its gel holds 15 mg/mL of BDDE cross-linked hyaluronic acid, with a degree of cross-linking below 10%, and 0.3% by mass of lidocaine hydrochloride. A box contains two pre-filled syringes, each supplied with two sterile 30G 1/2 inch needles and two traceability labels.

Najważniejsze zalety: Teosyal Puresense Redensity 2

  • Corrects superficial fine lines, wrinkles and depressions in the periorbital region
  • Indicated for the circle under the eyes, including the tear trough and palpebromalar groove
  • Hyaluronic acid at 15 mg/mL, a light concentration suited to thin periorbital skin
  • Evenly distributed in the injected tissue, maintaining an optimal level of dermal hydration and leading to a long-lasting improvement in skin elasticity
  • Degree of cross-linking below 10%, with residual BDDE below 1 ppm
  • Of non-animal origin
  • Contains lidocaine hydrochloride 0.3% by mass to reduce the sensation of pain
  • Two pre-filled syringes per box, each with two sterile 30G 1/2 inch needles
  • Estimated duration of at least 12 months
Najważniejsze informacje
Marka TEOSYAL
Producent Teoxane SA
Kraj pochodzenia Switzerland
Certyfikacja CE marked 2797 for the gel. The needles supplied are CE marked 0123 for TSK or 0197 for Terumo
Skład Hyaluronic acid of non-animal origin 15 mg/mL, cross-linked with BDDE (degree of cross-linking below 10%) at a mean molecular weight above 1 million Dalton; lidocaine hydrochloride 0.3% by mass; residual BDDE below 1 ppm; supplemented phosphate buffer pH 7.3 containing alpha-lipoic acid, glutathione, N-acetyl-L-cysteine, L-arginine, L-isoleucine, L-leucine, L-lysine monohydrate, glycine, L-valine, L-threonine, L-proline, pyridoxine hydrochloride, zinc acetate dihydrate, copper sulfate pentahydrate and sodium chloride
Objętość / Rozmiar 1 ml
Opakowanie 2 pre-filled syringes x 1 mL, each supplied with 2 sterile 30G 1/2 inch needles and 2 traceability labels
Rodzaj zastosowania Professional use only - injectable dermal filler with anaesthetic, for the periorbital and midface regions
Głębokość iniekcji Injected slowly at variable depths according to the area treated: into the dermis, subcutaneously, or onto the periosteum. Must not be injected into the epidermis, at depths other than those described, into or close to a blood vessel or nerve, or into layers above the muscle in the infraorbital region (under-eye hollow, tear trough). Compatibility has been verified with a TSK 25G/50 mm cannula as an alternative to the needle.
Protokół / Czas trwania Estimated lifetime of at least 12 months, varying with skin type, injection area, injected volume and patient lifestyle

Wskazania i zastosowanie profesjonalne

Główne wskazania

  • Correction of superficial fine lines, wrinkles and depressions in the periorbital region and in the midface (nasojugal groove)

Zastosowanie profesjonalne

TEOSYAL PureSense Redensity 2 is only to be administered by appropriately trained healthcare professionals who are qualified or accredited in accordance with national law, and is not for retail sale or self-administration. Periorbital treatment is among the most technically demanding injectable procedures and should be undertaken only by practitioners with specific training in the region. It must not be injected into the epidermis, into or close to a blood vessel, close to a nerve, or at depths other than those described. Depending on the correction required, one or more treatment sessions or a touch-up may be needed.

Obszary zabiegowe

  • Periorbital region: circle under the eyes, including the tear trough and palpebromalar groove, eyebrows, outer canthus, crow's feet
  • Midface: nasojugal groove

Profil pacjenta

For adults assessed as suitable by the treating practitioner. Patient selection matters particularly in this region, where skin is thin and any irregularity or excess volume is immediately visible. For injection in the infraorbital region it must not be used in patients with bags under the eyes (fatty orbital herniation or lymphatic stasis), lower eyelid hyperlaxity or any condition indicated for blepharoplasty. It must not be used in patients with cutaneous disorders, inflammation or infection at or near the treatment site, since injection procedures can lead to reactivation of latent or subclinical herpes viral infection. Because of the lidocaine content it must not be used in patients with known hypersensitivity to lidocaine or to amide local anaesthetics, or in patients with hepatocellular insufficiency or undergoing related treatment.

Jak działa Teosyal Puresense Redensity 2 ​

TEOSYAL PureSense Redensity 2 works through hyaluronic acid at 15 mg/mL, a light concentration chosen for the thinnest skin on the face. Hyaluronic acid binds water and fills the depression, while the low concentration keeps the correction subtle in a region where excess volume or superficial placement shows immediately. Placement is what defines this grade: it is the reference indicated for the circle under the eyes, covering the tear trough and palpebromalar groove, and extending to the nasojugal groove in the midface. The lidocaine hydrochloride at 0.3% reduces the sensation of pain during injection.

Dlaczego warto zamawiać w Allpara

Allpara oferuje oryginalne, sprawdzone produkty TEOSYAL od zweryfikowanych dostawców, z pełną identyfikowalnością partii i wsparciem ekspertów. Obsługujemy kliniki i specjalistów medycyny estetycznej, oferując produkty z oznakowaniem CE, szybką dostawę na terenie całej UE z naszego magazynu w UE oraz konkurencyjne ceny hurtowe. Najważniejsze są dla nas bezpieczeństwo, satysfakcja i efekty Twoich pacjentów - z indywidualnym wsparciem posprzedażowym dla Twojego spokoju.

Najczęściej zadawane pytania

How does Redensity 2 differ from Redensity 1?

They do different jobs. Redensity 2 carries 15 mg/mL hyaluronic acid cross-linked to below 10% and corrects superficial fine lines and depressions in the periorbital region, including the tear trough. Redensity 1 is a fluid, skin-quality product for hydration, texture and elasticity, and lasts at least 3 months against Redensity 2's at least 12.

How long does Redensity 2 last?

The estimated in vivo lifetime is at least 12 months. Duration depends on skin type, the injection area, the volume injected, and the patient's physiology and lifestyle.

Więcej od Teoxane

Zobacz laboratorium

Alternatywy dla kliniki

Wszystkie produkty

Teosyal Puresense Redensity 2

Dostępny
Oznakowanie CE Oznakowanie CE Teosyal Puresense Redensity 2
Ceny tylko dla zweryfikowanych
Zaloguj się lub załóż konto B2B, aby zobaczyć swoją cenę.
Konto B2B

TEOSYAL PureSense Redensity 2 is a transparent, sterile, non-pyrogenic and viscoelastic hyaluronic acid filler of non-animal origin from Teoxane SA in Geneva, created as the periorbital reference of the range. It is indicated to correct superficial fine lines, wrinkles and depressions located around the eyes. Its gel holds 15 mg/mL of BDDE cross-linked hyaluronic acid, with a degree of cross-linking below 10%, and 0.3% by mass of lidocaine hydrochloride. A box contains two pre-filled syringes, each supplied with two sterile 30G 1/2 inch needles and two traceability labels.

Najważniejsze zalety: Teosyal Puresense Redensity 2

  • Corrects superficial fine lines, wrinkles and depressions in the periorbital region
  • Indicated for the circle under the eyes, including the tear trough and palpebromalar groove
  • Hyaluronic acid at 15 mg/mL, a light concentration suited to thin periorbital skin
  • Evenly distributed in the injected tissue, maintaining an optimal level of dermal hydration and leading to a long-lasting improvement in skin elasticity
  • Degree of cross-linking below 10%, with residual BDDE below 1 ppm
  • Of non-animal origin
  • Contains lidocaine hydrochloride 0.3% by mass to reduce the sensation of pain
  • Two pre-filled syringes per box, each with two sterile 30G 1/2 inch needles
  • Estimated duration of at least 12 months
Najważniejsze informacje
Marka TEOSYAL
Producent Teoxane SA
Kraj pochodzenia Switzerland
Certyfikacja CE marked 2797 for the gel. The needles supplied are CE marked 0123 for TSK or 0197 for Terumo
Skład Hyaluronic acid of non-animal origin 15 mg/mL, cross-linked with BDDE (degree of cross-linking below 10%) at a mean molecular weight above 1 million Dalton; lidocaine hydrochloride 0.3% by mass; residual BDDE below 1 ppm; supplemented phosphate buffer pH 7.3 containing alpha-lipoic acid, glutathione, N-acetyl-L-cysteine, L-arginine, L-isoleucine, L-leucine, L-lysine monohydrate, glycine, L-valine, L-threonine, L-proline, pyridoxine hydrochloride, zinc acetate dihydrate, copper sulfate pentahydrate and sodium chloride
Objętość / Rozmiar 1 ml
Opakowanie 2 pre-filled syringes x 1 mL, each supplied with 2 sterile 30G 1/2 inch needles and 2 traceability labels
Rodzaj zastosowania Professional use only - injectable dermal filler with anaesthetic, for the periorbital and midface regions
Głębokość iniekcji Injected slowly at variable depths according to the area treated: into the dermis, subcutaneously, or onto the periosteum. Must not be injected into the epidermis, at depths other than those described, into or close to a blood vessel or nerve, or into layers above the muscle in the infraorbital region (under-eye hollow, tear trough). Compatibility has been verified with a TSK 25G/50 mm cannula as an alternative to the needle.
Protokół / Czas trwania Estimated lifetime of at least 12 months, varying with skin type, injection area, injected volume and patient lifestyle

Wskazania i zastosowanie profesjonalne

Główne wskazania

  • Correction of superficial fine lines, wrinkles and depressions in the periorbital region and in the midface (nasojugal groove)

Zastosowanie profesjonalne

TEOSYAL PureSense Redensity 2 is only to be administered by appropriately trained healthcare professionals who are qualified or accredited in accordance with national law, and is not for retail sale or self-administration. Periorbital treatment is among the most technically demanding injectable procedures and should be undertaken only by practitioners with specific training in the region. It must not be injected into the epidermis, into or close to a blood vessel, close to a nerve, or at depths other than those described. Depending on the correction required, one or more treatment sessions or a touch-up may be needed.

Obszary zabiegowe

  • Periorbital region: circle under the eyes, including the tear trough and palpebromalar groove, eyebrows, outer canthus, crow's feet
  • Midface: nasojugal groove

Profil pacjenta

For adults assessed as suitable by the treating practitioner. Patient selection matters particularly in this region, where skin is thin and any irregularity or excess volume is immediately visible. For injection in the infraorbital region it must not be used in patients with bags under the eyes (fatty orbital herniation or lymphatic stasis), lower eyelid hyperlaxity or any condition indicated for blepharoplasty. It must not be used in patients with cutaneous disorders, inflammation or infection at or near the treatment site, since injection procedures can lead to reactivation of latent or subclinical herpes viral infection. Because of the lidocaine content it must not be used in patients with known hypersensitivity to lidocaine or to amide local anaesthetics, or in patients with hepatocellular insufficiency or undergoing related treatment.

Jak działa Teosyal Puresense Redensity 2 ​

TEOSYAL PureSense Redensity 2 works through hyaluronic acid at 15 mg/mL, a light concentration chosen for the thinnest skin on the face. Hyaluronic acid binds water and fills the depression, while the low concentration keeps the correction subtle in a region where excess volume or superficial placement shows immediately. Placement is what defines this grade: it is the reference indicated for the circle under the eyes, covering the tear trough and palpebromalar groove, and extending to the nasojugal groove in the midface. The lidocaine hydrochloride at 0.3% reduces the sensation of pain during injection.

Dlaczego warto zamawiać w Allpara

Allpara oferuje oryginalne, sprawdzone produkty TEOSYAL z pełną identyfikowalnością partii, produktami z oznakowaniem CE, szybką dostawą na terenie całej UE i fachowym wsparciem posprzedażowym.

Najczęściej zadawane pytania

How does Redensity 2 differ from Redensity 1?

They do different jobs. Redensity 2 carries 15 mg/mL hyaluronic acid cross-linked to below 10% and corrects superficial fine lines and depressions in the periorbital region, including the tear trough. Redensity 1 is a fluid, skin-quality product for hydration, texture and elasticity, and lasts at least 3 months against Redensity 2's at least 12.

How long does Redensity 2 last?

The estimated in vivo lifetime is at least 12 months. Duration depends on skin type, the injection area, the volume injected, and the patient's physiology and lifestyle.

Więcej od Teoxane

Zobacz laboratorium →
* Produkt do użytku profesjonalnego. Opakowanie może się różnić w zależności od partii lub rynku. Pełne zalecenia i przeciwwskazania znajdziesz w dołączonej instrukcji użycia (IFU).